A hydrogen peroxide-tolerant Bifidobacterium longum strain improves colitis by resisting oxidative stress

Authors: Kim, Ji Hyung; Kim, Seung Won; Shin, Yoojin; Kim, Ki Beom; Park, I Seul; Son, Mijeong; Ma, Hyun Woo; Yong, Dongeun; Yoon, Sang Sun; Cheon, Jae Hee

Source journal: Inflammatory bowel diseases (2026-11-19)

DOI: 10.1093/ibd/izag235

Abstract

IMPORTANCE: Inflammation-associated oxidative stress can limit the viability and efficacy of obligate anaerobic probiotics such as Bifidobacterium. Inflammatory bowel disease (IBD) is characterized by sustained intestinal inflammation accompanied by elevated reactive oxygen species (ROS), creating an unfavorable niche for oxygen-sensitive commensals. OBJECTIVE: To evaluate the antioxidant, epithelial barrier-protective, and therapeutic potential of a hydrogen peroxide (H2O2)-resistant Bifidobacterium longum strain (S2). DESIGN: Experimental study involving in vitro functional assays, whole-genome sequencing, and three murine colitis models. SETTING: Laboratory-based cell culture and animal experiments. PARTICIPANTS: A bacterial strain isolated from healthy adult feces and mice with experimentally induced colitis. INTERVENTIONS OR EXPOSURES: Oral administration of S2, compared with vehicle or the reference strain ATCC 15697. MAIN OUTCOMES AND MEASURES: H2O2 tolerance, antioxidant activity, epithelial permeability, aryl hydrocarbon receptor (AhR) activity, fecal recovery, survival, clinical indices, histopathology, and mucus barrier markers. RESULTS: In vitro, S2 was significantly less inhibited by H2O2 and exhibited stronger radical-scavenging activity. S2 also reduced TNF-alpha- or LPS-induced epithelial permeability and increased aryl hydrocarbon receptor reporter activity. Whole-genome sequencing (2 365 469 bp; 59.94% G + C) placed S2 within the B. longum species and revealed genetic divergence from the H2O2-sensitive reference strain ATCC 15697. Consistent with robust survival under H2O2 exposure, genomic analysis showed a conserved thioredoxin/AhpC-centered peroxide detoxification system with additional redox-active enzymes. In vivo, oral administration of S2 resulted in higher fecal recovery than ATCC 15697, and viable recovery remained increased in RAG1-deficient mice, indicating that S2 persistence is not solely dependent on adaptive immunity. Importantly, across DSS, DNBS, and T-cell transfer colitis models, oral gavage of S2 significantly improved the survival rate, clinical indices, and histopathology while preserving goblet cells and mucin and increasing barrier-associated gene expression. CONCLUSIONS AND RELEVANCE: Collectively, these results identified B. longum S2 as an oxidative stress-tolerant probiotic candidate with barrier-protective and immunomodulatory effects, supporting a strategy of selecting oxidative stress-tolerant bifidobacterial strains to improve probiotic performance in ROS-rich intestinal inflammation such as IBD.

Read the full text

Related topics

Related open access articles

Abstract and bibliographic data from PubMed (U.S. National Library of Medicine). Copyright of the abstract belongs to the original publisher or authors.